Among these, 10 target genes (ACE2, HTR1A, HTR2A, AKT1, PKIA, CREB1, BDNF, BCL2, BAX, and CASP3), with higher degree were recognized as the major hub targets of XPF in treating CHD with depression. This evidence concerns the gene CREB1 and major depressive disorder.